本日の感染症学会教育講演（文献）

本日の感染症学会教育講演。お題は｢抗菌薬の考え方、使い方2010年バージョン」です。本日でてくる内容に関しての参考文献です。

Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001 Jun;24(6):1044-1049.

Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003 Feb;26(2):510-513.

Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect. Dis. Clin. North Am. 2007 Sep;21(3):617-638, vii.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 2004 Oct 1;39(7):885-910.

Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005;(3):CD000247.

Russo TA. Agents of Actinomycosis. Mandell: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Chapter 255. electric version. Churchill Livingstone, An Imprint of Elsevier

Sarcoma Nomogram Memorial Sloan-Kettering Cancer Center
http://www.mskcc.org/mskcc/html/6181.cfm

青木眞　レジデントのための感染症診療マニュアル第二版　医学書院
岩田健太郎（編）　感染症診療ガイドライン総まとめ　総合医学社

Fekety R, Silva J, Kauffman C, Buggy B, Deery HG. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am. J. Med. 1989 Jan;86(1):15-19.

Brismar B, Akerlund JE, Sjöstedt S, Johansson C, Törnqvist A, Bäckstrand B, et al. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group. Scand. J. Infect. Dis. 1996;28(5):507-512.

Kwon KT, Cheong HS, Rhee J, Wi YM, Ryu SY, Heo ST, et al. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial. Jpn. J. Clin. Oncol. 2008 Jan;38(1):49-55.

Kadowaki M, Demura Y, Mizuno S, Uesaka D, Ameshima S, Miyamori I, et al. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest. 2005 Apr;127(4):1276-1282.

Neu HC. The Quinolones. Infect Dis Clin North Am. 1989;3:625-639
2.O'Donnell JA, and Gelone SP. The newer fluoroquinolones. Infect Dis Clin North Am. 2004;18:691-716

Rubinstein E. History of quinolones and their side effects. Chemotherapy. 2001;47:3-8

Ball P, Mandell L, Niki Y, Tillotson G: Comparative tolerability of newer fluoroquinolone antibacterials. Drug Saf 1999;21:407-421

Cazzola M, Salvatori E, Dionisio P, and Allegra L. Prulifloxacin: A new fluoroquinolone for the treatment of acute exacerbation of chronic bronhcitis. Pulm Pharmacol Ther. 2006;19 Suppl 1:30-7

EMEA reports
http://www.docguide.com/news/content.nsf/news/852571020057CCF68525749000687709

http://www.dkma.dk/1024/visUKLSArtikel.asp?artikelID=13835

Wendt C, Schinke S, Württemberger M, Oberdorfer K, Bock-Hensley O, von Baum H. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol. 2007 Sep;28(9):1036-1043.

Bode LGM, Kluytmans JAJW, Wertheim HFL, Bogaers D, Vandenbroucke-Grauls CMJE, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 2010 Jan 7;362(1):9-17.

Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol. 2005 Dec;26(12):916-922.

Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GAJ, Stuurman A, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin. Infect. Dis. 2002 Aug 15;35(4):353-358.